期刊文献+

成纤维细胞生长因子23与早期糖尿病肾病的系统评价及meta分析 被引量:1

FGF23 and early stage of diabetic nephropathy:a systematic evaluation and meta analysis
下载PDF
导出
摘要 目的探讨成纤维细胞生长因子23(FGF23)水平在早期糖尿病肾病与单纯糖尿病患者中的差异。方法2019年8月通过计算机检索PubMed、MEDLINE、Cochrane Library、中文生物医学期刊文献数据库(CMCC)、中国知网(CNKI)、维普资讯中文期刊服务平台(VIP)、万方数据知识服务平台等数据库中相关文献,筛选关于比较早期糖尿病肾病(早期糖尿病肾病组)与单纯糖尿病患者(单纯糖尿病组)血清FGF23水平差异的观察性研究,并进行纳入文献的资料提取和质量评价。结果共纳入6项符合标准的横断面研究。与单纯糖尿病组比较,早期糖尿病肾病组患者血清FGF23水平明显增高,差异有统计学意义(加权均数差=15.29;95%可信区间:5.35~25.23;P<0.05,I2=96.6%]。结论早期糖尿病肾病与单纯糖尿病患者比较,血清FGF23水平明显升高,提示FGF23可能成为糖尿病肾病的新的标志物。 Objective To investigate the difference of fibroblast growth factor 23(FGF23)level in the patients with early stage of diabetic nephropathy(DN)and the patients with simple diabetes.Methods The related literatures were retrieved from the databases of PubMed,MEDLINE,Cochrane Library,CMCC,CNKI,VIP and Wanfang Data Knowledge Service Platform by computer.The observation studies on the comparison of serum FGF23 level between early DN(early DN group)and simple diabetes(simple diabetes group).Then the data extraction from the included literatures and quality evaluation were performed.Results Six cross-sectional studies conforming to the standard were included.Compared with the simple diabetes group,the level of serum FGF23 in the early DN group was significantly increased,and the difference was statistically significant(WMD=15.29;95%CI:5.35-25.23;P<0.05,I 2=96.6%).Conclusion Compared with simple diabetes,the serum FGF23 level in early DN is significantly increased,suggesting that FGF23 could become a new biomarker in DN.
作者 杨雪菲 李蓉 YANG Xuefei;LI Rong(Department of Endocrinology,First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
出处 《现代医药卫生》 2020年第15期2367-2370,共4页 Journal of Modern Medicine & Health
关键词 糖尿病肾病 糖尿病并发症 成纤维细胞生长因子 META分析 Diabetic nephropathies Diabetes complications Fibroblast growth factors Meta analysis
  • 相关文献

参考文献3

二级参考文献28

  • 1全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:708
  • 2Fliser D, Kollerits B, Neyer U, et al. Fibroblast growth factor 23 (FGF23)predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study[J]. J Am Soc Nephrol,2007,18(9) :2600-2608.
  • 3Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low leyels of microa Bumiriuria are associated with increased risk of coronary heart disease and death Inde- pendently of renal function, hypertension, and diabetes [J]. Circulation, 2004,110 (1) : 32-35.
  • 4Nauta FL, Boertien WE, Bakker SJ, et al. Glomerular and tubular damage markers are elevated in patients with dia- betes[J]. Diabetes Care,2011,34(4) :975-981.
  • 5Stubbs JR, He N, Idiculla A, et al. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease[J]. J Bone Miner Res,2012,27(1) :38-46.
  • 6Ferrari SL,BonSour JP,Rizzoli R. Fibroblast growth fac- tor-23 relationship to dietary phosphate and renal phos- phate handling in healthy young men[J]. J Clin Endocri- nol Metab,2005,90(3) :1519-1524.
  • 7Titan SM,Zatz R,Graciolli FG,et al. FGF-23 as a predic- tor of renal outcome in diabetic nephropathy[J]. Clin J Am Soc Nephrol,2011,6(2):241-247.
  • 8Fourtounas C. Phosphorus metabolism in chronic kidney disease[J]. Hippokratia, 2011,15 (1) : 50-52.
  • 9Marsell R, Jonsson KB. The phosphate regulating hor- mone fibroblast growth factor-23[J]. Acta Physiol (Oxf), 2010,200(2) : 97-106.
  • 10Manghat P, Fraser WD, Wierzbieki AS, et al. Fibroblast growth factor-23 is associated with C-reactive protein,se- rum phosphate and bone mineral density in chronic kid- ney disease[J]. Osteoporos Int,2010,21(11) :1853-1861.

共引文献15

同被引文献22

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部